A new study by researchers at Karolinska Institutet and Karolinska University Hospital shows that patients diagnosed with the rare skin cancers mycosis fungoides and Sézary syndrome face a significantly higher risk of dying from lymphoma and infections compared to the general population. The study was recently published in the British Journal of Dermatology.